Surgical management of implantation-related complications of the subcutaneous implantable cardioverter-defibrillator

TF Brouwer, AHG Driessen… - JACC: Clinical …, 2016 - jacc.org
Objectives: This study assessed outcomes in patients in whom subcutaneous implantable
cardioverter-defibrillator (S-ICD) therapy was continued after implantation-related …

[HTML][HTML] Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results

MR Gold, JD Aasbo, MF El-Chami, M Niebauer, J Herre… - Heart rhythm, 2017 - Elsevier
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review

CD Chue, CS Kwok, CW Wong, A Patwala, D Barker… - Heart, 2017 - heart.bmj.com
Background Subcutaneous implantable cardioverter defibrillators (S-ICDs) are considered
an alternative to conventional transvenous ICDs (TV-ICDs) in patients not requiring pacing …

“Shift and cover technique”: conservative management of complications for the rescue of S-ICD subcutaneous implantable defibrillator systems

A Droghetti, D Pecora, S Maffè, S Badolati… - Journal of Interventional …, 2022 - Springer
Background The risk of complications has been shown to be lower with subcutaneous
implantable defibrillator (S-ICD) than with conventional ICDs. Given the low frequency of …

Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience

A Gasperetti, M Schiavone, M Ziacchi, J Vogler… - Heart Rhythm, 2021 - Elsevier
Background Recently, the Food and Drug Administration issued a recall for the
subcutaneous implantable cardioverter-defibrillator (S-ICD) because of the possibility of …

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort

B Kattih, F Operhalski, F Boeckling, F Hecker… - Frontiers in …, 2022 - frontiersin.org
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has been
designed to overcome lead-related complications and device endocarditis. Lacking the …

Impact of Age on Subcutaneous Implantable Cardioverter-Defibrillator in a Large Patient Cohort: Mid-Term Follow-Up

R Weiss, BP Knight, M El-Chami, J Aasbo… - Clinical …, 2023 - jacc.org
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an accepted
alternative to transvenous (TV) ICD to provide defibrillation therapy to treat life-threatening …

Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study

L Boersma, C Barr, R Knops, D Theuns… - Journal of the American …, 2017 - jacc.org
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was
developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads …

Six‐year follow‐up of the initial Dutch subcutaneous implantable cardioverter‐defibrillator cohort: long‐term complications, replacements, and battery longevity

AFBE Quast, VF van Dijk, SC Yap… - Journal of …, 2018 - Wiley Online Library
Introduction Experience with the subcutaneous implantable cardioverter‐defibrillator (S‐
ICD) is expanding rapidly. However, data on long‐term performance or complications …

Postapproval study of a subcutaneous implantable cardioverter-defibrillator system

MR Gold, MF El-Chami, MC Burke… - Journal of the American …, 2023 - jacc.org
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …